Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia

BACKGROUND: Chemotherapy is still the standard regimen for treating acute myeloid leukemia (AML) and its disappointing efficacy requires the urgent need for new therapeutic targets. It is well known that immune response plays an increasingly significant role in the pathogenesis of AML. METHODS: We d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuyan, Li, Mingying, Meng, Guangqiang, Ma, Yuechan, Ye, Jingjing, Sun, Tao, Ji, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557852/
https://www.ncbi.nlm.nih.gov/pubmed/37602517
http://dx.doi.org/10.1002/cam4.6468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557852/
https://www.ncbi.nlm.nih.gov/pubmed/37602517
http://dx.doi.org/10.1002/cam4.6468

Ejemplares similares